Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Terri Smith-Weller is active.

Publication


Featured researches published by Terri Smith-Weller.


Neurology | 2003

Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes

Karen M. Powers; Terri Smith-Weller; Gary M. Franklin; W. T. Longstreth; Phillip D. Swanson; Harvey Checkoway

Background: Dietary influences on oxidative stress have been thought to play important role in the etiology of PD. Objective: To examine associations of PD with dietary nutrients, including minerals, vitamins, and fats. Methods: A population-based case-control study was conducted among newly diagnosed case (n = 250) and control subjects (n = 388) identified between 1992 and 2002 from enrollees of the Group Health Cooperative health maintenance organization in western Washington state. Controls were frequency matched to cases on sex and age. In-person interviews elicited data on food frequency habits during most of adult life. Nutrient intakes were calculated and analyzed by adjusting each person’s nutrient intake by their total energy intake (the nutrient density technique). Results: Subjects with an iron intake in the highest quartile compared with those in the lowest quartile had an increased risk of PD (odds ratio = 1.7, 95% CI: 1.0, 2.7, trend p = 0.016). There was an apparent joint effect of iron and manganese; dietary intake above median levels of both together conferred a nearly doubled risk compared with lower intakes of each nutrient (odds ratio = 1.9, 95% CI: 1.2, 2.9). No strong associations were found for either antioxidants or fats. Conclusion: A high intake of iron, especially in combination with high manganese intake, may be related to risk for PD.


Neurology | 2002

MR nerve imaging in a prospective cohort of patients with suspected carpal tunnel syndrome

Jeffrey G. Jarvik; Eric C. Yuen; David R. Haynor; Cynthia M. Bradley; Deborah Fulton-Kehoe; Terri Smith-Weller; R. Wu; Michel Kliot; George H. Kraft; Leo H. Wang; V. Erlich; Patrick J. Heagerty; Gary M. Franklin

Objectives To evaluate the reliability and diagnostic accuracy of high-resolution MRI of the median nerve in a prospectively assembled cohort of subjects with clinically suspected carpal tunnel syndrome (CTS). Methods The authors prospectively identified 120 subjects with clinically suspected CTS from five Seattle-area clinics. All subjects completed a hand-pain diagram and underwent a standardized nerve conduction study (NCS). The reference standard for determining CTS status was a classic or probable hand pain diagram and NCS with a difference >0.3 ms between the 8-cm median and ulnar peak latencies. Readers graded multiple imaging parameters of the MRI on four-point scales. The authors also performed quantitative measurements of both the median nerve and carpal tunnel cross-sectional areas. NCS and MRI were interpreted without knowledge of the other study or the hand pain diagram. Results Intrareader reliability was substantial to near perfect (kappa = 0.76 to 0.88). Interreader agreement was lower but still substantial (kappa = 0.60 to 0.67). Sensitivity of MRI was greatest for the overall impression of the images (96%) followed by increased median nerve signal (91%); however, specificities were low (33 to 38%). The length of abnormal signal on T2-weighted images was significantly correlated with nerve conduction latency, and median nerve area was larger at the distal radioulnar joint (15.8 vs 11.8 mm2) in patients with CTS. A logistic regression model combining these two MR variables had a receiver operating characteristic area under the curve of 0.85. Conclusions The reliability of MRI is high but the diagnostic accuracy is only moderate compared with a research-definition reference standard.


Movement Disorders | 1999

Dietary factors in Parkinson's disease: The role of food groups and specific foods

Cheryl M. Anderson; Harvey Checkoway; Gary M. Franklin; Shirley A. A. Beresford; Terri Smith-Weller; Phillip D. Swanson

The association between self‐reported past food intake and Parkinsons disease (PD) was investigated in a case‐control study of men and women aged 40–89 years.


Neurology | 1998

A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease

Harvey Checkoway; Gary M. Franklin; Paola Costa-Mallen; Terri Smith-Weller; Julia A. Dilley; Phillip D. Swanson; Lucio G. Costa

In a population-based case-control study, we found a reversal of the association of cigarette smoking with Parkinsons disease (PD) in relation to the monoamine oxidase B intron 13 genetic polymorphism. A reduced PD risk related to pack-years of smoking was detected for persons with the G allele, whereas an opposite effect was found among persons with the A allele. These results indicate an unexplained interaction between cigarette smoking and this genetic polymorphism.


American Journal of Medical Genetics | 1998

Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease

Paola Costa; Harvey Checkoway; Drew Levy; Terri Smith-Weller; Gary M. Franklin; Phillip D. Swanson; Lucio G. Costa

Monoamine oxidase B (MAO-B) is an enzyme that has relevance for Parkinson disease (PD) because of its roles in catabolizing dopamine and potentially activating exogenous neurotoxicants. A polymorphism of the gene encoding MAO-B has been identified as a single base change (A or G) in intron 13 of the X chromosome. The A allele was previously associated with an approximately twofold risk of PD. The present study compared A and G allele frequencies between newly diagnosed idiopathic PD cases and a control group free of neurodegenerative diseases. All study subjects were Caucasian. Cases were 37 men and 25 women, age 37-80 years; controls were 50 men and 29 women, age 45-82 years. MAO-B genotype was determined by the allele-specific polymerase chain reaction on DNA extracted from peripheral lymphocytes. In complete contrast to previous studies, elevated risks were detected with the G allele. The age-adjusted odds ratio for the G allele in males was 1.87 ((95% confidence interval) 0.78-4.47). Among females the age-adjusted odds ratios were 5.00 ((95% confidence interval) 1.13-22.1) for the GA genotype and 5.60 ((95% confidence interval) 1.01-30.9) for the GG genotype. These findings, although of limited statistical precision, suggest that the G allele of this MAO-B polymorphism may relate to PD risk.


Neuroscience Letters | 2003

Glutathione S-transferase M1, T1, and P1 polymorphisms and Parkinson's disease.

Samir N. Kelada; Patricia L. Stapleton; Federico M. Farin; Theo K. Bammler; David L. Eaton; Terri Smith-Weller; Gary M. Franklin; Phillip D. Swanson; William T. Longstreth; Harvey Checkoway

Oxidative stress is widely thought to contribute significantly to the pathogenesis Parkinsons disease (PD). Given the role of glutathione S-transferases (GSTs) in the conjugation of electrophiles and protection against reactive oxygen species, genes encoding the GSTs have been considered candidates for association studies of PD. We tested for associations between genotypes of GSTM1(homozygous deletion vs. non-deleted), GSTT1(homozygous deletion vs. non-deleted), and GSTP1 (Ile104Val and Ala113Val) and PD in a case-control study of 214 idiopathic PD cases and 330 age- and gender-matched, unrelated controls of Caucasian ethnicity. No significant associations with any of the GST genotypes were observed. However, there was a marginally significant difference in the distribution of GSTP1 104 genotypes between cases and controls (P=0.07), with an excess of Ile104Val heterozygotes found among cases (odds ratio (OR)=1.43; 95% Confidence Interval (CI): 0.98-2.08). This difference in the genotype distribution was strongest among smokers (OR for heterozygote=1.92; 95% CI: 1.12-3.29) versus non-smokers and among males (OR for heterozygote=1.99; 95% CI: 1.24-3.19) versus females. The distribution of GSTP1 Ile104Val and Ala113Val haplotypes did not differ between cases and controls. Taken together, these results suggest a potentially minor role of GSTP1 in PD, but do not give evidence for associations with either GSTM1 or GSTT1.


American Journal of Industrial Medicine | 2009

Occupational factors and risk of Parkinson's disease: A population-based case-control study.

Jordan A. Firestone; Jessica I. Lundin; Karen M. Powers; Terri Smith-Weller; Gary M. Franklin; Phillip D. Swanson; W. T. Longstreth; Harvey Checkoway

BACKGROUND Parkinsons disease (PD) has been associated with various workplace factors, but the evidence is inconsistent. OBJECTIVE To estimate the risk of PD associated with various jobs and workplace exposures. METHODS We conducted a population-based, case-control study of 404 incident PD cases and 526 age and sex-matched controls, collecting self-reported work histories including job titles and exposures to various industrial toxicants. Relative risks of PD from these exposures were estimated with odds ratios (OR) and 95% confidence intervals (CI) using logistic regression. RESULTS Risk was not significantly affected by farming work, by metal work, or by exposure to pesticides, metals, or solvents. CONCLUSIONS These findings do not provide support for the hypothesis that workplace factors affect the risk of PD.


Occupational and Environmental Medicine | 1999

Neuropsychological function in retired workers with previous long-term occupational exposure to solvents

William E. Daniell; Keith Claypoole; Harvey Checkoway; Terri Smith-Weller; Stephen R. Dager; Brenda D Townes; Linda Rosenstock

OBJECTIVES: It is plausible that neurodegenerative processes of aging might have a contributing role in the development of chronic effects of exposure to organic solvents. This study evaluated the risk for neuropsychological deficits among retired workers, relative to their histories of exposure to occupational solvents. METHODS: This cross sectional study evaluated retired male workers, 62-74 years of age, including 89 people with previous long-term occupational exposure to solvents (67 retired painters and 22 retired aerospace manufacturing workers), and 126 retired carpenters with relatively minimal previous exposure to solvents. Subjects completed a standardised neuropsychological evaluation and psychiatric interview, structured interviews for histories of occupational exposure and alcohol consumption, and questionnaires assessing neurological and depressive symptoms. RESULTS: By comparison with the carpenters, the painters on average reported greater cumulative alcohol consumption and had lower scores on the WAIS-R vocabulary subtest, usually presumed to reflect premorbid intellectual functioning. These findings, however, were not sufficient to account for the other study findings. Controlling for age, education, vocabulary score, and alcohol use, the painters had lower mean scores on test measures of motor, memory, and reasoning ability; and a subgroup of aerospace workers with moderate to high cumulative exposure to solvents (n = 8) had lower mean scores on measures of visuomotor speed, and motor, attention, memory, and reasoning ability. Subjects were more likely to have an increased number of relatively abnormal test scores (three or more outlier scores on 17 test measures) among both the painter group (odds ratio (OR), 3.1; 95% confidence interval (95% CI) 1.5 to 6.2) and the subgroup of aerospace workers with higher cumulative exposure (OR 5.6; 95% CI 1.0 to 38). The painters, but not the aerospace workers, reported significantly more neurological and depressive symptoms. CONCLUSIONS: The findings are consistent with residual central nervous system dysfunction from long-term exposure to organic solvents, persisting years after the end of exposure.


Movement Disorders | 2012

Environmental tobacco smoke and Parkinson's disease

Susan Searles Nielsen; Lisa G. Gallagher; Jessica I. Lundin; W. T. Longstreth; Terri Smith-Weller; Gary M. Franklin; Phillip D. Swanson; Harvey Checkoway

Parkinsons disease is inversely associated with cigarette smoking, but its relation with passive smoking or environmental tobacco smoke exposure is rarely examined.


Journal of Neurology, Neurosurgery, and Psychiatry | 2000

Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism

Paola Costa-Mallen; Lucio G. Costa; Terri Smith-Weller; Gary M. Franklin; Phillip D. Swanson; Harvey Checkoway

Genetic polymorphisms of dopamine D2 receptors (DRD2) may be susceptibility factors for Parkinsons disease due to their influence on dopamine response and association with cigarette smoking, which is inversely related to risk of Parkinsons disease. Relations of TaqIA and TaqIB DRD2 genotypes with Parkinsons disease were investigated and tested for interactive effects with smoking and the monoamine oxidase B (MAO-B) intron 13 polymorphism previously found to be related to smoking. Study subjects were 152 cases of idiopathic Parkinsons disease and 231 controls. The smoking history of all genotyped subjects was known. Subjects of genotype B12 were more frequent among cases than controls (27% and 23.8%, respectively), and were more frequent among “ever smokers” than “never smokers”, among controls (27.8% and 17.2%, respectively), although these associations were not statistically significant. Neither TaqIA or TaqIB genotypes modified the inverse relation of smoking and Parkinsons disease. When genotypes for DRD2 were considered in combination with genotypes for intron 13 of MAO-B, genotype combinations with high risk of Parkinsons disease were found; although the MAO-B/DRD2 interaction did not reach statistical significance after Bonferroni correction for multiple comparisons, these results are suggestive of a possible synergism between MAOB and DRD2 genes with respect to Parkinsons disease.

Collaboration


Dive into the Terri Smith-Weller's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge